- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Advanced non-squamous NSCLC
Total 25093 results
-
Novartis PharmaceuticalsNot yet recruitingOvarian Cancer | Lung Cancer
-
Astellas Pharma Global Development, Inc.Merck Sharp & Dohme LLC; Seagen Inc.RecruitingLocally Advanced or Metastatic Malignant Solid TumorsUnited States, Japan, Canada
-
Novartis PharmaceuticalsActive, not recruitingNon-small Cell Lung CancerUnited States, Canada, Italy, Spain, Malaysia, Taiwan, Turkey, Australia, Germany, Netherlands, Singapore, Argentina, Austria, Czechia, Switzerland, United Kingdom, Korea, Republic of, Thailand, France, Japan, Lebanon, Greece, Hong... and more
-
Novartis PharmaceuticalsTerminatedNon-small Cell Lung Cancer (NSCLC)Japan, Germany, Spain, Italy, France, Thailand, Belgium, Netherlands, India, Malaysia, Taiwan, Australia, Canada, Czechia, Greece, Hong Kong
-
CelgeneCompletedCarcinoma, Non-Small-Cell LungUnited States, Canada, France, Germany, Italy, Spain, United Kingdom
-
Novartis PharmaceuticalsWithdrawn
-
ETOP IBCSG Partners FoundationSpanish Lung Cancer GroupCompletedLung CancerSpain, Ireland, United Kingdom, Switzerland, France, Germany, Greece, Italy
-
West Virginia UniversityCelgene CorporationWithdrawnNon-small Cell Lung CancerUnited States
-
BeiGeneNot yet recruitingMetastatic Solid Tumor | Advanced Hepatocellular Carcinoma | Metastatic Hepatocellular Carcinoma | Alpha-fetoprotein (AFP)-Producing Gastric Cancer | Extragonadal Yolk Sac Tumors | Glypican-3 (GPC3)-Positive Squamous Non-small Cell Lung Cancer
-
National Cancer Centre, SingaporeRecruitingAdvanced EGFR Exon 20 Insertion Mutated Non-Small Cell Lung CancerKorea, Republic of, Taiwan, Singapore
-
National Cancer Center, ChinaNot yet recruiting
-
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...Not yet recruitingFirst-line Advanced NSCLC PatientsChina
-
Henan University of Traditional Chinese MedicineRecruiting
-
Changzhou No.2 People's HospitalNot yet recruitingNon-small Cell Lung Cancer
-
Eli Lilly and CompanyLoxo Oncology, Inc.RecruitingUterine Cervical Neoplasms | Carcinoma, Non-Small-Cell Lung | Colorectal Neoplasms | Ovarian Neoplasms | Endometrial Neoplasms | Triple Negative Breast Neoplasms | Pancreatic NeoplasmUnited States
-
Twinpig Biolab, Inc.Not yet recruitingHepatocellular Carcinoma | Colorectal Cancer | NSCLC | Prostate Cancer
-
Changhai HospitalShanghai Chest Hospital; Shanghai Changzheng Hospital; First Affiliated Hospital... and other collaboratorsRecruiting
-
Peking Union Medical College HospitalNot yet recruitingNon-small Cell Lung CancerChina
-
Shanghai JMT-Bio Inc.Not yet recruiting
-
BayerRecruitingHealthy Volunteers | Advanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 MutationUnited States
-
University Hospital, EssenGerman Cancer AidNot yet recruitingAdvanced Lung Carcinoma | NSCLC Stage IV | NSCLC Stage IIIB | First Line Treatment | Second Line Treatment | Palliative Treatment | NSCLC Stage IIICGermany
-
Henan Cancer HospitalJiangsu Simcere Pharmaceutical Co., Ltd.Not yet recruitingNon-small Cell Lung CancerChina
-
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...Recruiting
-
Sichuan Cancer Hospital and Research InstituteRecruitingALK-positive Non-small Cell Lung Cancer | Real World StudyChina
-
7 Hills Pharma, LLCNot yet recruitingMelanoma | Kidney Cancer | Renal Cell Carcinoma | Hepatocellular Carcinoma | Colorectal Cancer | NSCLC | Non Small Cell Lung Cancer | Skin Cancer | Metastasis | Advanced Solid Tumor | Advanced Cancer | Renal Cell Cancer | Hepatocellular Cancer | Mismatch Repair Deficiency | Pleural Mesothelioma | MSI-High | Anaplastic Lymphoma... and other conditionsUnited States
-
National Cancer Center, ChinaNot yet recruiting
-
Tianjin Medical University Cancer Institute and...RecruitingNon-small Cell Lung Cancer | EGFR Activating Mutation | EGFR-TKI Resistant Mutation | Cell Cycle DeregulationChina
-
BayerRecruitingHealthy Volunteers | Advanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 MutationUnited States
-
The First Affiliated Hospital, Guangzhou University...Not yet recruiting
-
AstraZenecaDaiichi SankyoRecruitingNon-Small Cell Lung CancerSpain, Italy, Japan, Brazil, Taiwan, Korea, Republic of, Australia, Austria, Canada, Poland, United States, Belgium, United Kingdom, Turkey, Hungary, Germany, India
-
Hunan Province Tumor HospitalNot yet recruitingNon-small Cell Lung CancerChina
-
Hunan Province Tumor HospitalNot yet recruitingNon-Small Cell Lung CancerChina
-
BayerRecruitingHealthy Volunteers | Advanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 MutationUnited States
-
AstraZenecaDaiichi SankyoNot yet recruitingNon-small Cell Lung CancerChina, Taiwan, Korea, Republic of, Australia
-
Guangzhou Institute of Respiratory DiseaseRecruiting
-
TheRas, Inc., d/b/a BridgeBio Oncology TherapeuticsRecruitingNSCLC | Metastatic Lung Cancer | Non-small Cell Lung Cancer | Advanced Lung Carcinoma | Metastatic Non-Small Cell Lung Cancer | KRAS G12CUnited States, Australia
-
Avistone Biotechnology Co., Ltd.RecruitingNon-Small-Cell Lung CancerChina
-
Second Affiliated Hospital of Xi'an Jiaotong UniversityNot yet recruitingNon Small Cell Lung Cancer
-
Shanghai Shengdi Pharmaceutical Co., LtdNot yet recruitingNon-squamous Non-small Cell Lung CancerChina
-
Jiangsu Province Nanjing Brain HospitalRecruiting
-
Memorial Sloan Kettering Cancer CenterAmgenRecruitingNon-Small Cell Lung CancerUnited States
-
AmgenRecruitingNon-small Cell Lung Cancer | Thoracic TumorsUnited States
-
BayerRecruitingHealthy Volunteers | Advanced Non-small Cell Lung Cancer | EGFR Mutation | HER2 MutationUnited Kingdom
-
Prince of Songkla UniversityRecruiting
-
Taizhou HospitalNot yet recruitingLung Cancer, Nonsmall Cell
-
Merck Sharp & Dohme LLCNot yet recruitingNon-small Cell Lung Cancer (NSCLC)
-
Tongji UniversityShanghai Pulmonary Hospital, Shanghai, ChinaNot yet recruiting
-
Dizal PharmaceuticalsRecruitingNon-small Cell Lung CancerChina
-
Yonsei UniversityNot yet recruitingNon Small Cell Lung CancerKorea, Republic of
-
Korea Institute of Oriental MedicineRecruitingNon-small Cell Lung CancerKorea, Republic of